Veeral Ajmera

Title(s)Associate Professor Of Clinical, Medicine
SchoolVc-health Sciences-schools
Address9500 Gilman Drive #
La Jolla CA 92093
vCardDownload vCard

    Collapse Overview 
    Collapse Websites

    Collapse Research 
    Collapse Research Activities and Funding
    A Novel Multimodal Approach to Characterize NAFLD Severity and Prognosis
    NIH K23DK119460Aug 16, 2019 - May 31, 2024
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse Publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Editorial: Genetics for noninvasive risk stratification-Finding the needle in the haystack: Authors' reply. Aliment Pharmacol Ther. 2024 Jun 25. Bridi L, Ajmera V. PMID: 38923033.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    2. The impact of genetic risk on the prevalence of advanced fibrosis and cirrhosis in prospectively assessed patients with type 2 diabetes. Aliment Pharmacol Ther. 2024 Jun 02. Bridi L, Agrawal S, Tesfai K, Madamba E, Bettencourt R, Richards LM, Khera AV, Loomba R, Ajmera V. PMID: 38825972.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    3. A prospective study on the prevalence of at-risk MASH in patients with type 2 diabetes mellitus in the United States. Aliment Pharmacol Ther. 2024 Apr 08. Mittal N, Siddiqi H, Madamba E, Richards L, Bettencourt R, Ajmera V, Loomba R. PMID: 38586922.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    4. Natural history of clinical outcomes and hepatic decompensation in metabolic dysfunction-associated steatotic liver disease. Aliment Pharmacol Ther. 2024 Apr 03. Noureddin N, Huang DQ, Bettencourt R, Siddiqi H, Majzoub AM, Nayfeh T, Tamaki N, Izumi N, Nakajima A, Idilman R, Gumussoy M, Oz DK, Erden A, Gidener T, Allen AM, Ajmera V, Loomba R. PMID: 38571305.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    5. Review article: New developments in biomarkers and clinical drug development in alpha-1 antitrypsin deficiency-related liver disease. Aliment Pharmacol Ther. 2024 Mar 22. Loomba R, Clark G, Teckman J, Ajmera V, Behling C, Brantly M, Brenner D, D'Armiento J, Fried MW, Iyer JS, Mandorfer M, Rockey DC, Tincopa M, Vuppalanchi R, Younossi Z, Krag A, Turner AM, Strnad P. PMID: 38516814.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    6. Prevalence of steatotic liver disease, MASLD, MetALD and significant fibrosis in people with HIV in the United States. Aliment Pharmacol Ther. 2024 Mar; 59(5):666-679. Gawrieh S, Vilar-Gomez E, Woreta TA, Lake JE, Wilson LA, Price JC, Naggie S, Sterling RK, Heath S, Corey KE, Cachay ER, Ajmera V, Tonascia J, Sulkowski MS, Chalasani N, Loomba R. PMID: 38158589; PMCID: PMC10922859.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    7. Low liver fat in non-alcoholic steatohepatitis-related significant fibrosis and cirrhosis is associated with hepatocellular carcinoma, decompensation and mortality. Aliment Pharmacol Ther. 2024 Jan; 59(1):80-88. Lee SW, Huang DQ, Bettencourt R, Ajmera V, Tincopa M, Noureddin N, Amangurbanova M, Siddiqi H, Madamba E, Majzoub AM, Nayfeh T, Tamaki N, Izumi N, Nakajima A, Yoneda M, Idilman R, Gumussoy M, Oz DK, Erden A, Loomba R. PMID: 37968251; PMCID: PMC10807727.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    8. Validation of AGA clinical care pathway and AASLD practice guidance for nonalcoholic fatty liver disease in a prospective cohort of patients with type 2 diabetes. Hepatology. 2024 May 01; 79(5):1098-1106. Ajmera V, Tesfai K, Sandoval E, Lopez S, Cervantes V, Madamba E, Bettencourt R, Manousou P, Richards L, Loomba R. PMID: 37862551; PMCID: PMC11023802.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    9. MEFIB-Index and MAST-Score in the assessment of hepatic decompensation in metabolic dysfunction-associated steatosis liver disease-Individual participant data meta-analyses. Aliment Pharmacol Ther. 2023 11; 58(9):856-865. Noureddin N, Ajmera V, Bergstrom J, Bettencourt R, Huang DQ, Siddiqi H, Majzoub AM, Nayfeh T, Tamaki N, Izumi N, Nakajima A, Idilman R, Gumussoy M, Oz DK, Erden A, Loomba R. PMID: 37694993; PMCID: PMC10901230.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    10. Ramipril for the Treatment of COVID-19: RAMIC, a Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Adv Ther. 2023 11; 40(11):4805-4816. Huang DQ, Ajmera V, Tomaszewski C, LaFree A, Bettencourt R, Thompson WK, Smith DM, Malhotra A, Mehta RL, Tolia V, Yin J, Insel PA, Leachman S, Jung J, Collier S, Richards L, Woods K, Amangurbanova M, Bhatt A, Zhang X, Penciu OM, Zarich S, Retta T, Harkins MS, Teixeira JP, Chinnock B, Utay NS, Lake JE, Loomba R. PMID: 37615850; PMCID: PMC10709987.
      View in: PubMed   Mentions:    Fields:    Translation:HumansCells
    11. Reply to: "Non-invasive testing for advanced fibrosis in patients with diabetes with fatty liver disease needs further evaluation of cut-off values". J Hepatol. 2023 Nov; 79(5):e192-e193. Ajmera V, Loomba R. PMID: 37517453.
      View in: PubMed   Mentions:    Fields:    
    12. Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysis. Lancet Gastroenterol Hepatol. 2023 09; 8(9):829-836. Huang DQ, Noureddin N, Ajmera V, Amangurbanova M, Bettencourt R, Truong E, Gidener T, Siddiqi H, Majzoub AM, Nayfeh T, Tamaki N, Izumi N, Yoneda M, Nakajima A, Idilman R, Gumussoy M, Oz DK, Erden A, Allen AM, Noureddin M, Loomba R. PMID: 37419133; PMCID: PMC10812844.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    13. Magnetic resonance elastography-based prediction model for hepatic decompensation in NAFLD: A multicenter cohort study. Hepatology. 2023 Dec 01; 78(6):1858-1866. Kim BK, Bergstrom J, Loomba R, Tamaki N, Izumi N, Nakajima A, Idilman R, Gumussoy M, Oz DK, Erden A, Truong E, Yang JD, Noureddin M, Allen AM, Loomba R, Ajmera V. PMID: 37203233; PMCID: PMC10663382.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    14. Editorial: "being normal weight each day keeps NAFLD and fibrosis away"-the importance of reducing cumulative exposure to overweight. Authors' reply. Aliment Pharmacol Ther. 2023 05; 57(10):1168-1169. Ajmera V. PMID: 37094321.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    15. Towards omics-based risk assessment in NAFLD. Nat Metab. 2023 04; 5(4):534-535. Ajmera V. PMID: 37037944.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    16. Longitudinal association between overweight years, polygenic risk and NAFLD, significant fibrosis and cirrhosis. Aliment Pharmacol Ther. 2023 05; 57(10):1143-1150. Ajmera V, Wang N, Xu H, Liu CT, Long MT. PMID: 36924053; PMCID: PMC10178778.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    17. Advances in the genetics of nonalcoholic fatty liver disease. Curr Opin Gastroenterol. 2023 05 01; 39(3):150-155. Ajmera V, Loomba R. PMID: 37144531; PMCID: PMC10167543.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    18. Genomic analysis of lean individuals with NAFLD identifies monogenic disorders in a prospective cohort study. JHEP Rep. 2023 Apr; 5(4):100692. Zheng M, Huang DQ, Konkwo C, Agrawal S, Khera AV, Loomba R, Vilarinho S, Ajmera V. PMID: 36937991; PMCID: PMC10017416.
      View in: PubMed   Mentions: 5  
    19. Reply to: "Screening for NAFLD and its severity in type 2 diabetic patients: Value of magnetic resonance imaging and outstanding issues". J Hepatol. 2023 05; 78(5):e168-e169. Ajmera V, Loomba R. PMID: 36736737; PMCID: PMC10121872.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    20. Psoriatic disease and non-alcoholic fatty liver disease shared pathogenesis review. Semin Arthritis Rheum. 2023 04; 59:152165. Torosian K, Lal E, Kavanaugh A, Loomba R, Ajmera V, Guma M. PMID: 36716599; PMCID: PMC9992353.
      View in: PubMed   Mentions: 3     Fields:    Translation:Humans
    21. Heart-liver-kidney transplantation for AL amyloidosis using normothermic recovery and storage from a donor following circulatory death: Short-term outcome in a first-in-world experience. Am J Transplant. 2023 02; 23(2):291-293. Brubaker AL, Urey MA, Taj R, Parekh JR, Berumen J, Kearns M, Shah M, Khan A, Kono Y, Ajmera V, Barman P, Tran H, Adler ED, Silva Enciso J, Asimakopoulos F, Costello C, Bower R, Sanchez R, Pretorius V, Schnickel GT. PMID: 36804136.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    22. Acute Fulminant Hepatic Failure in 23-Year-Old Female Taking Homeopathic Remedy. J Investig Med High Impact Case Rep. 2023 Jan-Dec; 11:23247096231207480. Goldhaber NH, Barnard Giustini A, Parekh J, Mekeel KL, Ajmera V. PMID: 37843100; PMCID: PMC10580716.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    23. A prospective study on the prevalence of NAFLD, advanced fibrosis, cirrhosis and hepatocellular carcinoma in people with type 2 diabetes. J Hepatol. 2023 03; 78(3):471-478. Ajmera V, Cepin S, Tesfai K, Hofflich H, Cadman K, Lopez S, Madamba E, Bettencourt R, Richards L, Behling C, Sirlin CB, Loomba R. PMID: 36410554; PMCID: PMC9975077.
      View in: PubMed   Mentions: 32     Fields:    Translation:Humans
    24. Risk of advanced fibrosis in first-degree relatives of patients with nonalcoholic fatty liver disease. J Clin Invest. 2022 11 01; 132(21). Tamaki N, Ahlholm N, Luukkonen PK, Porthan K, Sharpton SR, Ajmera V, Kono Y, Dave S, Ahmed A, Sundaram V, Wilkinson MJ, Patton H, Gupta H, Cervantes V, Hernandez C, Lopez SJ, Loomba R, Baumgartner A, Richards L, Arkkila PE, Nemes K, Isoniemi H, Yki-Järvinen H, Loomba R. PMID: 36317632; PMCID: PMC9621132.
      View in: PubMed   Mentions: 9     Fields:    Translation:Humans
    25. Single-center Experience on Nonlung Solid Organ Transplantation From SARS-CoV-2-positive Donors. Transplantation. 2023 01 01; 107(1):e41-e42. Covarrubias K, Brubaker AL, Mekeel K, Pretorius V, Shah M, Adler E, Ajmera V, Schnickel GT, Aslam S. PMID: 36240442; PMCID: PMC9746228.
      View in: PubMed   Mentions: 2     Fields:    Translation:HumansCells
    26. Liver Stiffness on Magnetic Resonance Elastography and the MEFIB Index and Liver-Related Outcomes in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis of Individual Participants. Gastroenterology. 2022 10; 163(4):1079-1089.e5. Ajmera V, Kim BK, Yang K, Majzoub AM, Nayfeh T, Tamaki N, Izumi N, Nakajima A, Idilman R, Gumussoy M, Oz DK, Erden A, Quach NE, Tu X, Zhang X, Noureddin M, Allen AM, Loomba R. PMID: 35788349; PMCID: PMC9509452.
      View in: PubMed   Mentions: 25     Fields:    Translation:Humans
    27. The Impact of Treatment of Hepatocellular Carcinoma With Immune Checkpoint Inhibitors on Pre- and Post-liver Transplant Outcomes. Transplantation. 2022 06 01; 106(6):e308-e309. Dave S, Yang K, Schnickel GT, Kono Y, Delebecque F, Arellano D, Liu A, Zhang X, Tu XM, Ajmera V. PMID: 35616911; PMCID: PMC9937048.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    28. Prognostic utility of magnetic resonance elastography and MEFIB index in predicting liver-related outcomes and mortality in individuals at risk of and with nonalcoholic fatty liver disease. Therap Adv Gastroenterol. 2022; 15:17562848221093869. Ajmera V, Nguyen K, Tamaki N, Sharpton S, Bettencourt R, Loomba R. PMID: 35509420; PMCID: PMC9058353.
      View in: PubMed   Mentions: 11  
    29. Liver transplantation for hepatocellular carcinoma following checkpoint inhibitor therapy with nivolumab. Am J Transplant. 2022 06; 22(6):1699-1704. Schnickel GT, Fabbri K, Hosseini M, Misel M, Berumen J, Parekh J, Mekeel K, Dehghan Y, Kono Y, Ajmera V. PMID: 35080128; PMCID: PMC9177653.
      View in: PubMed   Mentions: 18     Fields:    Translation:Humans
    30. Machine learning enables new insights into genetic contributions to liver fat accumulation. Cell Genom. 2021 Dec 08; 1(3). Haas ME, Pirruccello JP, Friedman SN, Wang M, Emdin CA, Ajmera VH, Simon TG, Homburger JR, Guo X, Budoff M, Corey KE, Zhou AY, Philippakis A, Ellinor PT, Loomba R, Batra P, Khera AV. PMID: 34957434; PMCID: PMC8699145.
      View in: PubMed   Mentions: 23     Fields:    
    31. Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD. Nat Rev Endocrinol. 2022 01; 18(1):55-66. Tamaki N, Ajmera V, Loomba R. PMID: 34815553; PMCID: PMC9012520.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    32. Rescue liver re-transplantation after graft loss due to severe rejection in the setting of pre-transplant nivolumab therapy. Clin J Gastroenterol. 2021 Dec; 14(6):1718-1724. Dehghan Y, Schnickel GT, Hosseini M, Burgoyne AM, Ajmera VH, Morris GP, Mendler MH, Parekh JR, Abushamat F, Vodkin I, Kono Y. PMID: 34643885; PMCID: PMC8557174.
      View in: PubMed   Mentions: 5     Fields:    Translation:Humans
    33. Emerging Role of Genomic Analysis in Clinical Evaluation of Lean Individuals With NAFLD. Hepatology. 2021 10; 74(4):2241-2250. Vilarinho S, Ajmera V, Zheng M, Loomba R. PMID: 34233030; PMCID: PMC8463418.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    34. TVB-2640 (FASN Inhibitor) for the Treatment of Nonalcoholic Steatohepatitis: FASCINATE-1, a Randomized, Placebo-Controlled Phase 2a Trial. Gastroenterology. 2021 11; 161(5):1475-1486. Loomba R, Mohseni R, Lucas KJ, Gutierrez JA, Perry RG, Trotter JF, Rahimi RS, Harrison SA, Ajmera V, Wayne JD, O'Farrell M, McCulloch W, Grimmer K, Rinella M, Wai-Sun Wong V, Ratziu V, Gores GJ, Neuschwander-Tetri BA, Kemble G. PMID: 34310978.
      View in: PubMed   Mentions: 54     Fields:    Translation:HumansCellsCTClinical Trials
    35. Optimal Threshold of Controlled Attenuation Parameter for Detection of HIV-Associated NAFLD With Magnetic Resonance Imaging as the Reference Standard. Clin Infect Dis. 2021 06 15; 72(12):2124-2131. Ajmera VH, Cachay ER, Ramers CB, Bassirian S, Singh S, Bettencourt R, Richards L, Hamilton G, Middleton M, Fowler K, Sirlin C, Loomba R. PMID: 32975278; PMCID: PMC8204791.
      View in: PubMed   Mentions: 7     Fields:    Translation:Humans
    36. The impact of genetic risk on liver fibrosis in non-alcoholic fatty liver disease as assessed by magnetic resonance elastography. Aliment Pharmacol Ther. 2021 07; 54(1):68-77. Ajmera V, Liu A, Bettencourt R, Dhar D, Richards L, Loomba R. PMID: 33975381; PMCID: PMC8985656.
      View in: PubMed   Mentions: 12     Fields:    Translation:Humans
    37. Clinical utility of 30% relative decline in MRI-PDFF in predicting fibrosis regression in non-alcoholic fatty liver disease. Gut. 2022 05; 71(5):983-990. Tamaki N, Munaganuru N, Jung J, Yonan AQ, Loomba RR, Bettencourt R, Ajmera V, Valasek MA, Behling C, Sirlin CB, Loomba R. PMID: 33883248; PMCID: PMC8594562.
      View in: PubMed   Mentions: 27     Fields:    Translation:Humans
    38. RAMIC: Design of a randomized, double-blind, placebo-controlled trial to evaluate the efficacy of ramipril in patients with COVID-19. Contemp Clin Trials. 2021 04; 103:106330. Ajmera V, Thompson WK, Smith DM, Malhotra A, Mehta RL, Tolia V, Yin J, Sriram K, Insel PA, Collier S, Richards L, Loomba R. PMID: 33631357; PMCID: PMC7899027.
      View in: PubMed   Mentions: 5     Fields:    Translation:HumansCellsPHPublic HealthCTClinical Trials
    39. Relationship of ELF and PIIINP With Liver Histology and Response to Vitamin E or Pioglitazone in the PIVENS Trial. Hepatol Commun. 2021 May; 5(5):786-797. Gawrieh S, Wilson LA, Yates KP, Cummings OW, Vilar-Gomez E, Ajmera V, Kowdley KV, Rosenberg WM, Tonascia J, Chalasani N. PMID: 34027269; PMCID: PMC8122381.
      View in: PubMed   Mentions: 8     Fields:    
    40. Imaging biomarkers of NAFLD, NASH, and fibrosis. Mol Metab. 2021 08; 50:101167. Ajmera V, Loomba R. PMID: 33460786; PMCID: PMC8324681.
      View in: PubMed   Mentions: 48     Fields:    Translation:Humans
    41. Association of Genetic Variation With Cirrhosis: A Multi-Trait Genome-Wide Association and Gene-Environment Interaction Study. Gastroenterology. 2021 04; 160(5):1620-1633.e13. Emdin CA, Haas M, Ajmera V, Simon TG, Homburger J, Neben C, Jiang L, Wei WQ, Feng Q, Zhou A, Denny J, Corey K, Loomba R, Kathiresan S, Khera AV. PMID: 33310085; PMCID: PMC8035329.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    42. Clinical Utility of Change in Nonalcoholic Fatty Liver Disease Activity Score and Change in Fibrosis in NAFLD. Clin Gastroenterol Hepatol. 2021 12; 19(12):2673-2674.e3. Tamaki N, Munaganuru N, Jung J, Yonan AQ, Bettencourt R, Ajmera V, Valasek MA, Behling C, Loomba R. PMID: 33157318; PMCID: PMC8438785.
      View in: PubMed   Mentions: 4     Fields:    Translation:Humans
    43. Association between plasminogen activator inhibitor-1 in young adulthood and nonalcoholic fatty liver disease in midlife: CARDIA. Liver Int. 2020 05; 40(5):1111-1120. Campbell PT, VanWagner LB, Colangelo LA, Lewis CE, Henkel A, Ajmera VH, Lloyd-Jones DM, Vaughan DE, Khan SS. PMID: 32090434; PMCID: PMC7823725.
      View in: PubMed   Mentions: 6     Fields:    Translation:Humans
    44. Clinical Utility of an Increase in Magnetic Resonance Elastography in Predicting Fibrosis Progression in Nonalcoholic Fatty Liver Disease. Hepatology. 2020 03; 71(3):849-860. Ajmera VH, Liu A, Singh S, Yachoa G, Ramey M, Bhargava M, Zamani A, Lopez S, Mangla N, Bettencourt R, Rizo E, Valasek M, Behling C, Richards L, Sirlin C, Loomba R. PMID: 31556124; PMCID: PMC7828573.
      View in: PubMed   Mentions: 42     Fields:    Translation:Humans
    45. Standardising the interpretation of liver biopsies in non-alcoholic fatty liver disease clinical trials. Aliment Pharmacol Ther. 2019 11; 50(10):1100-1111. Pai RK, Kleiner DE, Hart J, Adeyi OA, Clouston AD, Behling CA, Jain D, Kakar S, Brahmania M, Burgart L, Batts KP, Valasek MA, Torbenson MS, Guindi M, Wang HL, Ajmera V, Adams LA, Parker CE, Feagan BG, Loomba R, Jairath V. PMID: 31583739; PMCID: PMC6817398.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    46. Provider Attitudes and Practice Patterns for Direct-Acting Antiviral Therapy for Patients With Hepatocellular Carcinoma. Clin Gastroenterol Hepatol. 2020 04; 18(4):974-983. Rich NE, Yang JD, Perumalswami PV, Alkhouri N, Jackson W, Parikh ND, Mehta N, Salgia R, Duarte-Rojo A, Kulik L, Rakoski M, Said A, Oloruntoba O, Ioannou GN, Hoteit MA, Moon AM, Rangnekar AS, Eswaran SL, Zheng E, Jou JH, Hanje J, Pillai A, Hernaez R, Wong R, Scaglione S, Samant H, Kapuria D, Chandna S, Rosenblatt R, Ajmera V, Frenette CT, Satapathy SK, Mantry P, Jalal P, John BV, Fix OK, Leise M, Lindenmeyer CC, Flores A, Patel N, Jiang ZG, Latt N, Dhanasekaran R, Odewole M, Kagan S, Marrero JA, Singal AG. PMID: 31357028; PMCID: PMC8174017.
      View in: PubMed   Mentions: 10     Fields:    Translation:Humans
    47. MRI Assessment of Treatment Response in HIV-associated NAFLD: A Randomized Trial of a Stearoyl-Coenzyme-A-Desaturase-1 Inhibitor (ARRIVE Trial). Hepatology. 2019 11; 70(5):1531-1545. Ajmera VH, Cachay E, Ramers C, Vodkin I, Bassirian S, Singh S, Mangla N, Bettencourt R, Aldous JL, Park D, Lee D, Blanchard J, Mamidipalli A, Boehringer A, Aslam S, Leinhard OD, Richards L, Sirlin C, Loomba R. PMID: 31013363; PMCID: PMC7164416.
      View in: PubMed   Mentions: 17     Fields:    Translation:Humans
    48. Liver Stiffness Severity is Associated With Increased Cardiovascular Risk in Patients With Type 2 Diabetes. Clin Gastroenterol Hepatol. 2020 03; 18(3):744-746.e1. Mangla N, Ajmera VH, Caussy C, Sirlin C, Brouha S, Bajwa-Dulai S, Madamba E, Bettencourt R, Richards L, Loomba R. PMID: 31100460; PMCID: PMC6984972.
      View in: PubMed   Mentions: 13     Fields:    Translation:Humans
    49. Serum metabolites detect the presence of advanced fibrosis in derivation and validation cohorts of patients with non-alcoholic fatty liver disease. Gut. 2019 10; 68(10):1884-1892. Caussy C, Ajmera VH, Puri P, Hsu CL, Bassirian S, Mgdsyan M, Singh S, Faulkner C, Valasek MA, Rizo E, Richards L, Brenner DA, Sirlin CB, Sanyal AJ, Loomba R. PMID: 30567742; PMCID: PMC8328048.
      View in: PubMed   Mentions: 29     Fields:    Translation:Humans
    50. Longer lactation duration is associated with decreased prevalence of non-alcoholic fatty liver disease in women. J Hepatol. 2019 01; 70(1):126-132. Ajmera VH, Terrault NA, VanWagner LB, Sarkar M, Lewis CE, Carr JJ, Gunderson EP. PMID: 30392752; PMCID: PMC6599460.
      View in: PubMed   Mentions: 20     Fields:    Translation:Humans
    51. Host Genetic Variant in CXCL16 May Be Associated With Hepatitis B Virus-Related Acute Liver Failure. Cell Mol Gastroenterol Hepatol. 2019; 7(2):477-479.e4. Ajmera V, Huang H, Dao D, Feld JJ, Lau DT, Patel K, Rule JA, Daly M, Lee WM, Chung RT. PMID: 30827414; PMCID: PMC6409437.
      View in: PubMed   Mentions: 1     Fields:    Translation:HumansCells
    52. Emerging Role of the Gut Microbiome in Nonalcoholic Fatty Liver Disease: From Composition to Function. Clin Gastroenterol Hepatol. 2019 01; 17(2):296-306. Sharpton SR, Ajmera V, Loomba R. PMID: 30196156; PMCID: PMC6314895.
      View in: PubMed   Mentions: 62     Fields:    Translation:Humans
    53. Refining Sample-Size Estimations Based Upon Placebo Response in Trials of Agents for Nonalcoholic Fatty Liver Disease. Clin Gastroenterol Hepatol. 2019 03; 17(4):607-609. Ajmera V, Loomba R. PMID: 30153521.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    54. Link between gut-microbiome derived metabolite and shared gene-effects with hepatic steatosis and fibrosis in NAFLD. Hepatology. 2018 09; 68(3):918-932. Caussy C, Hsu C, Lo MT, Liu A, Bettencourt R, Ajmera VH, Bassirian S, Hooker J, Sy E, Richards L, Schork N, Schnabl B, Brenner DA, Sirlin CB, Chen CH, Loomba R, Genetics of NAFLD in Twins Consortium. PMID: 29572891; PMCID: PMC6151296.
      View in: PubMed   Mentions: 87     Fields:    Translation:Humans
    55. Magnetic Resonance Imaging Proton Density Fat Fraction Associates With Progression of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 2018 08; 155(2):307-310.e2. Ajmera V, Park CC, Caussy C, Singh S, Hernandez C, Bettencourt R, Hooker J, Sy E, Behling C, Xu R, Middleton MS, Valasek MA, Faulkner C, Rizo E, Richards L, Sirlin CB, Loomba R. PMID: 29660324; PMCID: PMC6090543.
      View in: PubMed   Mentions: 66     Fields:    Translation:Humans
    56. Among Patients With Nonalcoholic Fatty Liver Disease, Modest Alcohol Use Is Associated With Less Improvement in Histologic Steatosis and Steatohepatitis. Clin Gastroenterol Hepatol. 2018 09; 16(9):1511-1520.e5. Ajmera V, Belt P, Wilson LA, Gill RM, Loomba R, Kleiner DE, Neuschwander-Tetri BA, Terrault N, Nonalcoholic Steatohepatitis Clinical Research Network. PMID: 29378307; PMCID: PMC6098737.
      View in: PubMed   Mentions: 45     Fields:    Translation:Humans
    57. Hilar cholangiocarcinoma associated with immunoglobulin G4-positive plasma cells and elevated serum immunoglobulin G4 levels. Hepatol Commun. 2018 04; 2(4):349-353. Azeem N, Ajmera V, Hameed B, Mehta N. PMID: 29619414; PMCID: PMC5880190.
      View in: PubMed   Mentions: 3     Fields:    
    58. Can Elastography Differentiate Isolated Fatty Liver from Nonalcoholic Steatohepatitis? Semin Liver Dis. 2018 02; 38(1):14-20. Ajmera V, Loomba R. PMID: 29471562.
      View in: PubMed   Mentions: 10     Fields:    Translation:HumansAnimals
    59. Optimal threshold of controlled attenuation parameter with MRI-PDFF as the gold standard for the detection of hepatic steatosis. Hepatology. 2018 04; 67(4):1348-1359. Caussy C, Alquiraish MH, Nguyen P, Hernandez C, Cepin S, Fortney LE, Ajmera V, Bettencourt R, Collier S, Hooker J, Sy E, Rizo E, Richards L, Sirlin CB, Loomba R. PMID: 29108123; PMCID: PMC5867216.
      View in: PubMed   Mentions: 137     Fields:    Translation:Humans
    60. Do Zones of Hepatic Steatosis Associate With Subtypes and Progression of Nonalcoholic Fatty Liver Disease in Children? Clin Gastroenterol Hepatol. 2018 03; 16(3):341-342. Ajmera V, Loomba R. PMID: 29199148; PMCID: PMC5881903.
      View in: PubMed   Mentions: 1     Fields:    Translation:Humans
    61. Alcohol Use and Cardiovascular Disease Risk in Patients With Nonalcoholic Fatty Liver Disease. Gastroenterology. 2017 11; 153(5):1260-1272.e3. VanWagner LB, Ning H, Allen NB, Ajmera V, Lewis CE, Carr JJ, Lloyd-Jones DM, Terrault NA, Siddique J. PMID: 28802566; PMCID: PMC5669829.
      View in: PubMed   Mentions: 26     Fields:    Translation:Humans
    62. Association Between Cytokines and Liver Histology in Children with Nonalcoholic Fatty Liver Disease. Hepatol Commun. 2017 Sep; 1(7):609-622. Perito ER, Ajmera V, Bass NM, Rosenthal P, Lavine JE, Schwimmer JB, Yates KP, Diehl AM, Molleston JP, Murray KF, Scheimann A, Gill R, Glidden D, Aouizerat B. PMID: 29130075; PMCID: PMC5679472.
      View in: PubMed   Mentions: 11     Fields:    
    63. Editorial: non-alcoholic fatty liver disease-a pandemic in need of novel treatments and endpoints. Aliment Pharmacol Ther. 2017 07; 46(1):65-66. Ajmera V, Loomba R. PMID: 28589576; PMCID: PMC5501982.
      View in: PubMed   Mentions:    Fields:    Translation:HumansPHPublic Health
    64. Is moderate alcohol use in nonalcoholic fatty liver disease good or bad? A critical review. Hepatology. 2017 06; 65(6):2090-2099. Ajmera VH, Terrault NA, Harrison SA. PMID: 28100008; PMCID: PMC5444963.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    65. Testosterone Levels in Pre-Menopausal Women are Associated With Nonalcoholic Fatty Liver Disease in Midlife. Am J Gastroenterol. 2017 05; 112(5):755-762. Sarkar M, Wellons M, Cedars MI, VanWagner L, Gunderson EP, Ajmera V, Torchen L, Siscovick D, Carr JJ, Terry JG, Rinella M, Lewis CE, Terrault N. PMID: 28291240; PMCID: PMC5664187.
      View in: PubMed   Mentions: 30     Fields:    Translation:Humans
    66. Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease. Hepatology. 2017 01; 65(1):65-77. Ajmera V, Perito ER, Bass NM, Terrault NA, Yates KP, Gill R, Loomba R, Diehl AM, Aouizerat BE, NASH Clinical Research Network. PMID: 27532276; PMCID: PMC5191932.
      View in: PubMed   Mentions: 72     Fields:    Translation:Humans
    67. Gestational Diabetes Mellitus Is Strongly Associated With Non-Alcoholic Fatty Liver Disease. Am J Gastroenterol. 2016 05; 111(5):658-64. Ajmera VH, Gunderson EP, VanWagner LB, Lewis CE, Carr JJ, Terrault NA. PMID: 27002796; PMCID: PMC4860097.
      View in: PubMed   Mentions: 41     Fields:    Translation:Humans
    68. Nonalcoholic fatty liver disease activity score and mortality: Imperfect but not insignificant. Hepatology. 2016 07; 64(1):309-10. Ajmera V. PMID: 26517408; PMCID: PMC4851904.
      View in: PubMed   Mentions: 2     Fields:    Translation:Humans
    69. Use of nucleoside (tide) analogues in patients with hepatitis B-related acute liver failure. Dig Dis Sci. 2012 May; 57(5):1349-57. Dao DY, Seremba E, Ajmera V, Sanders C, Hynan LS, Lee WM, Acute Liver Failure Study Group. PMID: 22198704; PMCID: PMC3565239.
      View in: PubMed   Mentions: 13     Fields:    Translation:HumansCells
    70. What factors determine the severity of hepatitis A-related acute liver failure? J Viral Hepat. 2011 Jul; 18(7):e167-74. Ajmera V, Xia G, Vaughan G, Forbi JC, Ganova-Raeva LM, Khudyakov Y, Opio CK, Taylor R, Restrepo R, Munoz S, Fontana RJ, Lee WM, Acute Liver Failure Study Group. PMID: 21143345; PMCID: PMC4931904.
      View in: PubMed   Mentions: 20     Fields:    Translation:HumansCells
    Veeral's Networks
    Concepts (178)
    Derived automatically from this person's publications.
    _
    Co-Authors (80)
    People in Profiles who have published with this person.
    _
    Similar People (60)
    People who share similar concepts with this person.
    _
    Same Department
    Search Department
    _